To include your compound in the COVID-19 Resource Center, submit it here.

Theravance, GSK report Relovair data

Theravance Inc. (NASDAQ:THRX) and partner GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said Relovair fluticasone/vilanterol met five of the

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE